Long-term Efficacy and Safety of Inebilizumab for Neuromyelitis Optica Spectrum Disorder in the Randomized, Double-blind N-MOmentum Study and Extension (3998)
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available